Steven Cohen's KNSA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 640,958 shares of Kiniksa Pharmaceuticals International, plc (KNSA) worth $30.86 M, representing 0.04% of the portfolio. First purchased in 2018-Q2, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in KNSA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 1.15 M shares. Largest reduction occurred in Q2 2022, reducing 329,798 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Kiniksa Pharmaceuticals International plc (KNSA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kiniksa Pharmaceuticals International plc (KNSA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -156,179 | Reduce 19.59% | 640,958 | $48.15 |
| Q4 2025 | +230,210 | Add 40.61% | 797,137 | $41.25 |
| Q3 2025 | -281,622 | Reduce 33.19% | 566,927 | $38.83 |
| Q2 2025 | -300,862 | Reduce 26.18% | 848,549 | $27.67 |
| Q1 2025 | +1.15 M | New Buy | 1.15 M | $22.21 |
| Q2 2022 | -329,798 | Sold Out | 0 | $0.00 |
| Q1 2022 | -68,554 | Reduce 17.21% | 329,798 | $9.94 |
| Q4 2021 | +23,252 | Add 6.20% | 398,352 | $11.77 |
| Q3 2021 | +375,100 | New Buy | 375,100 | $11.39 |
| Q2 2021 | -219,800 | Sold Out | 0 | $0.00 |
| Q1 2021 | +219,800 | New Buy | 219,800 | $18.51 |
| Q4 2019 | -140,000 | Sold Out | 0 | $0.00 |
| Q3 2019 | +105,000 | Add 300.00% | 140,000 | $8.51 |
| Q2 2019 | +35,000 | New Buy | 35,000 | $13.54 |
| Q3 2018 | -5,000 | Sold Out | 0 | $0.00 |
| Q2 2018 | +5,000 | New Buy | 5,000 | $17.40 |
Steven Cohen's Kiniksa Pharmaceuticals International plc Investment FAQs
Steven Cohen first purchased Kiniksa Pharmaceuticals International, plc (KNSA) in Q2 2018, acquiring 5,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Kiniksa Pharmaceuticals International, plc (KNSA) for 16 quarters since Q2 2018.
Steven Cohen's largest addition to Kiniksa Pharmaceuticals International, plc (KNSA) was in Q1 2025, adding 1,149,411 shares worth $25.53 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 640,958 shares of Kiniksa Pharmaceuticals International, plc (KNSA), valued at approximately $30.86 M.
As of the Q1 2026 filing, Kiniksa Pharmaceuticals International, plc (KNSA) represents approximately 0.04% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Kiniksa Pharmaceuticals International, plc (KNSA) was 1,149,411 shares, as reported at the end of Q1 2025.